MedTrace Logo

Modification of Asthma With Soy Isoflavone

NCT00741208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-06-08

No results posted yet for this study

Summary

The purpose of this study is to determine if dietary supplementation with soy isoflavones in persistent asthma improves airway reactivity as determined by PC20 to methacholine.

Conditions

Interventions

DIETARY_SUPPLEMENT

Soy Isoflavone

50mg soy isoflavone supplement consumed twice daily for a total of 100mg of soy isoflavones per day.

Sponsors & Collaborators

Principal Investigators

  • Ravi Kalhan, MD, MS · Northwestern University

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00741208 on ClinicalTrials.gov